Cosmeceutical Ingredients and Hair Growth Claims

A growing number of hair serums are marketed as alternatives or additions to established hair loss treatments. Some contain specialized peptides, while others use botanical extracts or combinations of naturally occurring and laboratory-developed compounds. Although these products are frequently grouped together in hair growth marketing, they are not a single, scientifically established category of treatments. Their ingredients, proposed effects and supporting research differ considerably.

Peptides are short chains of amino acids that can help cells communicate and respond to signals within the body. Certain peptides have attracted interest for their potential effects on hair follicles, although promising laboratory findings do not necessarily mean they can produce noticeable hair regrowth in humans. Capixyl combines acetyl tetrapeptide-3 with red clover extract and is marketed for its potential benefits in reducing hair loss. Procapil combines biotinoyl tripeptide-1 with apigenin and oleanolic acid and is promoted for its possible effects on hair growth and DHT-related activity. While both ingredients have attracted commercial interest, independent clinical evidence demonstrating consistent, long-term effectiveness against androgenetic alopecia remains limited.

Other widely marketed ingredients rely on combinations of botanical extracts and additional compounds. Redensylcontains several substances, including compounds derived from larch and green tea, along with glycine and zinc. It is promoted for its proposed effects on cells involved in hair growth. AnaGain, derived from pea sprouts, is marketed for its potential influence on the hair growth cycle, while Baicapil combines extracts from baikal skullcap, soy and wheat sprouts and is promoted for its possible benefits in reducing shedding and improving hair density.

These proprietary ingredients have generated considerable interest, and some human studies involving products that contain them have reported encouraging results. However, much of the research comes from ingredient suppliers, manufacturers or relatively small studies involving several ingredients used together. When a serum contains multiple potentially active substances, improvements observed during a study cannot automatically be attributed to any one ingredient. Similarly, favorable results involving one product do not establish that other products containing similar ingredients will work equally well.

Other topical ingredients, including adenosine, caffeine and melatonin, have also been investigated for their potential effects on hair growth. Unlike some proprietary ingredient combinations, these substances have been examined in a broader range of published human studies. Topical adenosine has shown encouraging findings in some trials involving hair thickness and growth, although a recent analysis of the available research did not establish consistent benefits across the measurements examined. Caffeine has also demonstrated potential in human studies, but much of the evidence remains limited by study design and quality.

Topical melatonin has been investigated in several human studies, with some reporting improvements in hair shedding and other hair growth measurements. However, differences in product concentrations, treatment methods and study populations make it difficult to draw firm conclusions about its effectiveness for androgenetic alopecia. Although these ingredients warrant continued investigation, the available evidence does not establish that they consistently produce results comparable to established medical treatments.

The distinction between research on an ingredient and research on the actual product being sold is particularly important. Concentration, formulation and the combination of ingredients can all influence how a product performs. Consumers should be cautious about assuming that a serum is effective simply because it contains a recognizable ingredient associated with promising research.

Evaluating the Evidence and the AHLA Perspective 

One of the greatest challenges facing consumers is distinguishing promising scientific research from marketing claims that go beyond the available evidence. Cosmeceutical manufacturers frequently promote products using laboratory findings, testimonials, before-and-after photographs and references to clinical studies. However, demonstrating that an ingredient affects cells or processes associated with hair growth in a laboratory does not establish that a commercially available serum can prevent androgenetic alopecia or produce noticeable hair regrowth.

The quality of human research also varies considerably. Some studies involve relatively small numbers of participants, short treatment periods or products containing several potentially active ingredients. Others lack appropriate comparison groups, making it difficult to determine whether improvements were caused by the product being studied. Some studies are funded by the companies selling the products, while others are conducted or supported by the suppliers of proprietary ingredients. Industry-funded research is not automatically unreliable, but financial relationships should be disclosed, and findings deserve greater confidence when they are independently confirmed.

Even when a study reports an increase in hair count or a reduction in shedding, consumers should consider whether the improvement is noticeable and whether the results are likely to continue with long-term use. A measurable change over a few months does not necessarily mean that a product can prevent progressive hair loss. Consumers should also ask whether the actual product being sold was tested in people with their type of hair loss, how long the study lasted and whether it was compared with a placebo or another appropriate treatment.

Safety and product quality are equally important. Topical cosmeceuticals may cause itching, redness, irritation or allergic reactions, particularly when they contain multiple active ingredients, fragrances or other potentially irritating substances. Products marketed as gentle or naturally derived are not necessarily free of side effects, and the absence of reported problems in a small, short-term study does not establish long-term safety. Consumers who experience persistent irritation or worsening scalp symptoms should discontinue the product and seek appropriate medical advice.

The FDA does not recognize cosmeceuticals as a separate legal category. Cosmetic products generally do not require FDA approval before being sold, although manufacturers must comply with applicable safety, labeling and reporting requirements. Products that make claims about treating hair loss or restoring hair growth may be regulated as drugs, regardless of whether they are advertised as cosmetics. Marketing terms such as clinically tested, dermatologist recommended or scientifically formulated should not be confused with FDA approval or proof of effectiveness.

The American Hair Loss Association recognizes that research into specialized topical ingredients may lead to useful advances in the management of hair loss. Some cosmeceutical ingredients have demonstrated encouraging early findings, and responsible manufacturers that invest in meaningful clinical research and quality control should be distinguished from companies relying primarily on aggressive marketing. However, scientific credibility requires more than an appealing explanation of how an ingredient might work, a trademarked ingredient name or endorsements from healthcare professionals.

Consumers should evaluate these products based on the strength of the clinical evidence, the transparency of the manufacturer, ingredient quality, safety and realistic expectations about the results. Some cosmeceuticals may eventually offer useful additional options for selected individuals, but they should not be promoted as proven replacements for established medical treatments without appropriate clinical evidence.

The AHLA believes emerging cosmeceutical ingredients deserve objective scientific evaluation, not automatic endorsement or dismissal. Our priority is to help consumers distinguish legitimate research and potentially beneficial products from exaggerated claims, while encouraging higher standards of clinical evidence and transparency throughout the hair loss industry.